Murray Raskind

发表

Assessment of Agitation in Alzheimer's Disease: The Agitated Behavior in Dementia Scale

Linda Teri, Ronald G. Thomas, M. Weiner, 1999, Journal of the American Geriatrics Society.

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Eden R Martin, Seth Love, Brian Lawlor, 2019, Nature Genetics.

Depression in Kraepelinian schizophrenia.

M. Raskind, Murray Raskind, Nael Kilzieh, 2003, Comprehensive psychiatry.

Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis

Robert C. Green, Andrew J. Saykin, Liana G. Apostolova, 2012, Nature Genetics.

Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study

Robert C. Green, Andrew J. Saykin, Liana G. Apostolova, 2020, Nature Communications.

Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series

Linda Teri, David Nochlin, E. Larson, 1999, Journal of the American Geriatrics Society.

Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy.

Jeffrey Cummings, Jiska Cohen-Mansfield, Helena C Kraemer, 2008, The Journal of clinical psychiatry.

Prevention of posttraumatic stress disorder.

M. Raskind, Murray Raskind, S. Thorp, 2011, The Psychiatric clinics of North America.

Insulin Metabolism in Alzheimer’s Disease Differs According to Apolipoprotein E Genotype and Gender

Sanjay Asthana, Suzanne Craft, J. Newcomer, 1999, Neuroendocrinology.

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis

Nick C Fox, Jerome Barakos, Donatella Tampieri, 2012, The Lancet Neurology.